Side-by-side on funding, valuation, status, and the rest of the FOBI roster.
Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.
Reads and modulates the vagus nerve to treat chronic inflammatory diseases using implantable neural interfaces.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →
| Valuation |
$430MLatest valuation |
| — |
| Founders | Grégoire Courtine, Jocelyne Bloch | Emil Hewage, Oliver Armitage |
| Profile | View on FOBI → | View on FOBI → |